1 2 3 4 5 6 7 8 9
читать далее ... Nerve sparing radical prostatectomy: A different view. J Urol 1995:154:145-149 28. Hollenbeck BK, Dunn RL, WeiJTetal. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol 2003:169: 1453-1457 29 Raina R, taken MM, Agarwal A et ill. Longterm effect of Sildenafil citrate on erectile dysfunction after radical prostatectomy: а Зуеаг follow/up. Urology 2003; 62:110 115 30. Begg CB, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N EngI J Med 2002; 346:11381144 31. Hong EK, Lepor H, McCullough AR. Time dependent patient satisfaction with sildenafil for erectile dysfunction after nerve sparing radical retropubic prostatecfomy. Int J Impot Res 1999, 11(suppl.1);15-22 32 MontorsiF, Maga T, StrambiLFetal. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000; 20(56):906-11 33. Padma-Nathan H, McCullough A, Forest C. Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies. Curr Urol Rep 2004: 5:467-471 34. McCullough AR, Barada JH, Fawzy A et al. Achieving treatment optimization with Sildenafil citrate in patients with erectile function. Urology 2002: 60.2837 35. El Galley R, Rutland H, Talic R et al. Longterm efficacy of Sildenafil and tachyphylaxis effect. J Urol 2001: 166:927931 36. Montorsi F, MeDermott ТЕ, Morgan R et al. Efficacy and safety of fixed dose oral Sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 1999; 53:10111018 37. Steers WD Tachyphylaxis and pbosphodiesterase type 5 inhibitors. J Urol 2002; 168:207-209 38. Boolell M, Alien Ml, Ballard SA et al. Sildenafil: an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996: 8:47-52 39. Padma Nathan H, Eardley I, Kloner RA et al. A 4 year update on the safety of Sildenafil citrate (Viagra). Urology 2002: 60:67-90 40. Carson CC. Sildenafil citrate treatment for erectile dysfunction: rate of adverse events decreases with time. J Urol 2002; 167 (suppl):.179-183Источник: Гамидов С.И., Иремашвили В.В. Русский медицинский журнал. 2005. Т.13. №25. С.1683-1687